| Previous close | 93.08 |
| Open | 93.99 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 91.33 - 94.03 |
| 52-week range | 80.60 - 104.32 |
| Volume | |
| Avg. volume | 1,384,522 |
| Market cap | 114.712B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 25.46 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.76 (4.04%) |
| Ex-dividend date | 13 May 2024 |
| 1y target est | N/A |
- Zacks
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Regeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
- Insider Monkey
Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript
Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript April 25, 2024 Sanofi reports earnings inline with expectations. Reported EPS is $0.96 EPS, expectations were $0.96. Sanofi isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Paul Hudson: Welcome to the Q1 2024 conference […]
- Zacks
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
© 2024 Yahoo. All rights reserved.